Mauriello

Adamis Pharmaceuticals Stock Analysis ADMP

做多
NASDAQ:ADMP   None
The Idea is to go long as per Technical and Fundamental Analysis. Wait the possible end of the price set back before going long.
Shares of Adamis Pharmaceuticals Corporation ADMP surged 77.6% after it submitted an investigational new drug (IND) application to the FDA to begin a clinical study onTempol for thetreatment and prevention ofCOVID-19.
NASDAQ:ADMP

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。